Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Jul, 30 2026
May, 20 2026
Dec, 2 2025
May, 11 2026
Feb, 26 2026